Compare Compass Inc. Class A Common Stock (COMP) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Compass Inc. Class A Common Stock vs Immunovant Inc. Common Stock — how do they compare? Compass Inc. Class A Common Stock trades at $9.52 (market cap $7.05B), while Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B). The key difference: Compass Inc. Class A Common Stock and Immunovant Inc. Common Stock are close in size by market cap, and Compass Inc. Class A Common Stock is more actively traded (15,310,192 versus 1,131,364). Which is the better fit depends on your goals — on Pluang, investors hold Compass Inc. Class A Common Stock for 0 Days and Immunovant Inc. Common Stock for 0 Days on average.
| COMP | IMVT | |
|---|---|---|
Market Cap | $7.05B | $6.62B |
Volume | 15,310,192 | 1,131,364 |
Sector | Real Estate | Health |
52-Week High | $13.58 | $44.96 |
52-Week Low | $6.68 | $17.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.47B | $5.72B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Compass Inc. Class A Common Stock
Compass is a technology-enabled residential real estate company. Its platform provides agents with tools for customer relationships, marketing, client service, and transactions, alongside brokerage, title, escrow, and mortgage services.
Read more on COMP →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
